BMC cancer
Prevalence and therapeutic response of EGFR T790I mutation in NSCLC patients with acquired resistance to EGFR-TKIs: a retrospective cohort study.
Jingwei Shi, Ye Wang, Jiaohui Pang, Jiani C Yin, Chunhong He, Zhi Zhang, Haiyan Xie
Published: 202510.1186/s12885-025-14885-4
No abstract available for this study.